Stability and release of topical tranexamic acid liposome formulations

被引:0
|
作者
Manosroi, A [1 ]
Podjanasoonthon, K [1 ]
Manosroi, J [1 ]
机构
[1] Chiang Mai Univ, Fac Pharm, Pharmaceut Cosmet Raw Mat & Nat Prod Res & Dev Ctr, Inst Sci & Technol Res & Dev, Chiang Mai 50200, Thailand
关键词
D O I
暂无
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Tranexamic acid (TA) has been claimed to have whitening effects. The effects of TA contents (5% and 10%) and charges on the stability and release of TA entrapped in hydrogenated soya phosphatidylcholine/cholesterol/charged lipid {dicetyl phosphate (-) or stearylamine (+)} liposomes at molar ratios of 7:2:1(-) and 7:2:1 (+) were investigated. The TA contents were determined spectrophotometrically at 415 nm, following derivatization with 2,4,6-trinitrobenzosulfonic acid. Stability and leakage of TA from liposomes were characterized at 4degrees, 30degrees and 45degreesC for 90 days. The leakage rates of TA in negative liposomes were lower than those in positive liposomes. The TA in all liposome formulations was relatively stable, as > 90% of total drug remained after up to two months. The release of TA from liposomes was examined using vertical Franz diffusion cells at 37degreesC for 24 h. The release rates of TA from all liposome formulations were similar to 3 times lower than those from solutions. Charges appeared to affect the physical stability, leakage, and shelf life of TA in liposomes, whereas TA concentrations seemed to affect the release of TA. The 7:2:1 (10% TA,-) liposome was the best formulation, due to its small size, low leakage, high stability, and prolonged and sustained release profile.
引用
收藏
页码:375 / 386
页数:12
相关论文
共 50 条
  • [1] Development of novel topical tranexamic acid liposome formulations
    Manosroi, A
    Podjanasoonthon, K
    Manosroi, J
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 235 (1-2) : 61 - 70
  • [2] Stability and transdermal absorption of topical amphotericin B liposome formulations
    Manosroi, A
    Kongkaneramit, L
    Manosroi, J
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 270 (1-2) : 279 - 286
  • [3] In vitro release, rheological, and stability studies of mefenamic acid coprecipitates in topical formulations
    Ahmed, Tarek A.
    Ibrahim, Hany M.
    Ibrahim, Fathy
    Samy, Ahmed M.
    Fetoh, Ehab
    Nutan, Mohammad T. H.
    [J]. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2011, 16 (05) : 497 - 510
  • [4] Topical Formulations and Intradermal Injections of Tranexamic Acid in the Treatment of Hyperpigmentation - A Review
    Batory, Mirella
    Rotsztejn, Helena
    [J]. LETTERS IN DRUG DESIGN & DISCOVERY, 2018, 15 (02) : 212 - 218
  • [5] The effect of different lipid components on the in vitro stability and release kinetics of liposome formulations
    Anderson, M
    Omri, A
    [J]. DRUG DELIVERY, 2004, 11 (01) : 33 - 39
  • [6] Combination of Oral Tranexamic Acid with Topical 3% Tranexamic Acid versus Oral Tranexamic Acid with Topical 20% Azelaic Acid in the Treatment of Melasma
    Malik, Fahmida
    Hanif, Malik Muhammad
    Mustafa, Ghulam
    [J]. JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2019, 29 (06): : 502 - 504
  • [7] In vitro retinoic acid release and skin permeation from different liposome formulations
    Montenegro, L
    Panico, AM
    Ventimiglia, A
    Bonina, FP
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 133 (1-2) : 89 - 96
  • [8] Novel formulations for topical delivery of tranexamic acid: assessing the need of epidermal targeting for hyperpigmentation disorders
    Verma, Piyush
    Yadav, Khushwant S.
    [J]. EXPERT OPINION ON DRUG DELIVERY, 2023, 20 (06) : 773 - 783
  • [9] STABILITY OF TOPICAL ERYTHROMYCIN FORMULATIONS
    VANDENBOSSCHE, GMR
    VANHAECKE, E
    DEMUYNCK, C
    REMON, JP
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1991, 67 (02) : 195 - 199
  • [10] Topical tranexamic acid for spontaneous epistaxis
    Jesus Santander, Maria
    Rosenbaum, Andres
    Winter, Matias
    [J]. MEDWAVE, 2018, 18 (08):